Nanogen and Aventis R&T Form SNP Analysis Joint Venture | GenomeWeb

NEW YORK, July 17 – Nanogen and Aventis Research and Technologies have formed a joint venture, Nanogen Recognomics, to develop new products and applications for Nanogen’s NanoChip SNP analysis system, Nanogen said Tuesday.

The new Frankfurt-based company, 60 percent owned by Nanogen and 40 percent by Aventis R&T, will focus on developing genetic-based diagnostics, screening, and detection techniques, including those using novel oligonucleotide attachment chemistries.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.